Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS) (Q35620372)
Jump to navigation
Jump to search
scientific article published on 28 February 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS) |
scientific article published on 28 February 2011 |
Statements
1 reference
Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS) (English)
1 reference
Christiane Rordorf
1 reference
Abhijit Chakraborty
1 reference
Stacey Tannenbaum
1 reference
Norbert Blank
1 reference
Joachim Roesler
1 reference
Sandra D Felix
1 reference
Jasmin B Kuemmerle-Deschner
1 reference
Eduardo Ramos
1 reference
Thomas Jung
1 reference
Kirstin Stricker
1 reference
Andrew M Wright
1 reference
28 February 2011
1 reference
1 reference
13
1 reference
1
1 reference
R34
1 reference
1 February 2011
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference